Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Tang Capital Management Llc
Form 13F · Q2 2026

Tang Capital Management Llc

CIK 1232621Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$2.2B
Reported book value
41
Positions
12
Quarters on record
Top 50
Positions

Tang Capital Management Llc — holdings

Top 40 positions of 41, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1AUPH Aurinia Pharmaceuticals Inc13.0M+6.7%$221M10.1%
2SYRE Spyre Therapeutics Inc1.9M+0.0%$168M7.6%
3MIRM Mirum Pharmaceuticals Inc1.2M+0.0%$145M6.6%
4KINIKSA PHARMACEUTICALS INTL Kiniksa Pharmaceuticals Intl2.3M+0.0%$145M6.6%
5CELC Celcuity Inc1.3M+25.2%$138M6.2%
6CORT Corcept Therapeutics Inc1.5M+0.0%$130M5.9%
7PTCT Ptc Therapeutics Inc1.5M+0.0%$122M5.6%
8LKFT Lakefront Biotherapeutics3.8M+0.0%$114M5.2%
9CAPR Capricor Therapeutics Inc4.1M+20.6%$99M4.5%
10TARS Tarsus Pharmaceuticals Inc1.6M+31.9%$99M4.5%
11SPY State Str Spdr S&P 500 Etf T123,000−26.8%$92M4.2%
12ANAB Anaptysbio Inc1.3M+0.0%$90M4.1%
13IMCR Immunocore Hldgs Plc2.6M+0.0%$84M3.8%
14CMPS Compass Pathways Plc5.0M+24.9%$71M3.2%
15ANIP Ani Pharmaceuticals Inc707,500+0.0%$59M2.7%
16BNTX Biontech Se470,000+0.0%$44M2.0%
17CMPX Compass Therapeutics Inc18.0M+7.1%$39M1.8%
18PGEN Precigen Inc6.4M+0.0%$37M1.7%
19VRDN Viridian Therapeutics Inc1.8M+0.0%$33M1.5%
20NVCT Nuvectis Pharma Inc1.6M—$29M1.3%
21DNTH Dianthus Therapeutics Inc264,692+0.0%$26M1.2%
22FULC Fulcrum Therapeutics Inc6.5M—$24M1.1%
23AVIR Atea Pharmaceuticals Inc4.8M+0.0%$22M1.0%
24CBIO Crescent Biopharma Inc.1.2M+0.0%$21M0.9%
25NNDM Nano Dimension Ltd14.3M—$21M0.9%
26VKTX Viking Therapeutics Inc500,000+0.0%$20M0.9%
27NUVB Nuvation Bio Inc3.3M+4.8%$19M0.9%
28IDYA Ideaya Biosciences Inc450,000+0.0%$17M0.8%
29DERM Journey Med Corp1.6M+0.0%$11M0.5%
30INSM Insmed Inc100,000−61.5%$11M0.5%
31STOK Stoke Therapeutics Inc300,000−40.0%$10M0.4%
32PLRX Pliant Therapeutics Inc6.1M−0.0%$7M0.3%
33BOLD Boundless Bio Inc2.6M—$6M0.3%
34PMVP Pmv Pharmaceuticals Inc4.2M+0.0%$6M0.3%
35MRNA Moderna Inc50,000−50.0%$4M0.2%
36WVE Wave Life Sciences Ltd600,000+0.0%$3M0.2%
37HRTX Heron Therapeutics Inc6.2M+0.0%$3M0.1%
38LENZ Lenz Therapeutics Inc451,114+0.0%$3M0.1%
39ALT Altimmune Inc666,022+0.0%$2M0.1%
40RCKT Rocket Pharmaceuticals Inc100,000+0.0%$342,0000.0%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.